Literature DB >> 23613612

Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266.

Mayer B Davidson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613612      PMCID: PMC3631822          DOI: 10.2337/dc12-2225

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
This letter is in response to Pilz et al. (1) who are concerned about the possible long-term effects of high levels of vitamin D on mortality. In a sense, our study was a “proof of concept” one. As noted in our article (2) and in its Supplementary Table 3, there have been a number of studies evaluating the effect of vitamin D supplementation on diabetes, insulin secretion, and insulin sensitivity, almost all of which have been negative. There are five possible reasons for these negative results: 1) some subjects did not have hypovitaminosis D; 2) the dose of vitamin D was too low; 3) relatedly, achieved serum vitamin D levels were not high enough; 4) duration of treatment was too short; or 5) vitamin D supplementation was truly ineffective. We chose conditions to meet the first four situations, i.e., subjects with hypovitaminosis D at high risk for developing diabetes and treated them for 1 year with very high doses of vitamin D (88,865 IU per week or 12,695 per day) quickly achieving serum levels of nearly 70 ng/mL. Thus, our negative results strongly support the fifth reason, i.e., vitamin D supplementation is simply ineffective in delaying the development of diabetes in people at high risk who have low levels of vitamin D or in their ability to secrete or respond to insulin. Pilz et al. (1) point out that in a meta-analysis of 14 prospective cohort studies evaluating serum vitamin D levels and mortality, a few suggested a U-shaped relationship (3). However, this suggestion was not confirmed in a recently published National Health and Nutrition Examination Survey study (4). Although our study was certainly not intended to help establish acceptable vitamin D doses, the lack of hypercalcemia and hypercalciuria while ingesting nearly 13,000 IU of vitamin D per day for a year may help meet potential reservations concerning the recommendations of The Endocrine Society that a tolerable dose of vitamin D is 10,000 IU per day.
  4 in total

1.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies.

Authors:  Armin Zittermann; Simona Iodice; Stefan Pilz; William B Grant; Vincenzo Bagnardi; Sara Gandini
Journal:  Am J Clin Nutr       Date:  2011-12-14       Impact factor: 7.045

2.  Mortality rates across 25-hydroxyvitamin D (25[OH]D) levels among adults with and without estimated glomerular filtration rate <60 ml/min/1.73 m2: the third national health and nutrition examination survey.

Authors:  Holly Kramer; Chris Sempos; Guichan Cao; Amy Luke; David Shoham; Richard Cooper; Ramon Durazo-Arvizu
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

3.  Comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266.

Authors:  Stefan Pilz; Femke Rutters; Jacqueline M Dekker
Journal:  Diabetes Care       Date:  2013-05       Impact factor: 19.112

4.  High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D.

Authors:  Mayer B Davidson; Petra Duran; Martin L Lee; Theodore C Friedman
Journal:  Diabetes Care       Date:  2012-10-01       Impact factor: 19.112

  4 in total
  1 in total

Review 1.  Low vitamin D status and obesity: Role of nutritionist.

Authors:  Silvia Savastano; Luigi Barrea; Maria Cristina Savanelli; Francesca Nappi; Carolina Di Somma; Francesco Orio; Annamaria Colao
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.